Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Both sides next revision |
pharmaceutical_companies:arbutus_biopharma [2023/03/16 17:36]
liam | pharmaceutical_companies:arbutus_biopharma [2023/03/16 18:48] (current)
liam |
|---|
| ==== COVID-19 ==== | ==== COVID-19 ==== |
| |
| On March 10, 2023, U.S. District Judge [[:Mitchell Goldberg]] rejected a bid by [[Moderna]] to dismiss some of the patent infringement claims brought against the company by Arbutus and its partner, [[Genevant Sciences]].((Stieber, Z. (2023, March 13). //Judge Rejects Request From Moderna, Moving Key COVID-19 Vaccine Case to Discovery.// The Epoch Times. https://archive.ph/YyqVf)) ((Goldberg, J. (2023). //Case 1:22-cv-00252-MSG Document 64.// In [[:Document Cloud]]. [[:United States District Court for the District of Delaware]]. https://web.archive.org/web/20230316161451/https://s3.documentcloud.org/documents/23706145/moderna-covid-19-opinion.pdf)) | On March 10, 2023, U.S. District Judge [[:Mitchell Goldberg]] rejected a bid by [[Moderna]] to dismiss some of the patent infringement claims brought against the company by Arbutus and its partner, [[Genevant Sciences]].((Stieber, Z. (2023, March 13). //Judge Rejects Request From Moderna, Moving Key COVID-19 Vaccine Case to Discovery.// The Epoch Times. https://archive.ph/YyqVf)) ((Goldberg, M. (2023). //Case 1:22-cv-00252-MSG Document 64.// In [[:Document Cloud]]. [[:United States District Court for the District of Delaware]]. https://web.archive.org/web/20230316161451/https://s3.documentcloud.org/documents/23706145/moderna-covid-19-opinion.pdf)) |
| |
| ===== External links ===== | ===== External links ===== |
| |
| * [[https://en.wikipedia.org/wiki/Arbutus_Biopharma|Wikipedia]] | * [[https://en.wikipedia.org/wiki/Arbutus_Biopharma|Wikipedia]] |
